is glp-1 dangerous SAHPRA warns the public about products sold through social media platforms GLP-1 Agonists - What is
Description
Multiple GLP-1R agonists have entered into clinical trials, such as semaglutide, progressing to approval
It can increase the level of serotonin in the brain, thereby alleviating emotions and improving sleep
Currently GLP1s have a warning about the risk of medullary thyroid cancer
| 40 comments on LinkedIn
March 25, 2024
